Results 121 to 130 of about 138,725 (257)

Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report

open access: yesJournal of Dermatological Treatment
In this report, we describe the case of a 28-year-old female with bilateral breast cancer in the setting of a BRCA1 mutation, who presented to dermatology with an eczematous reaction, ultimately diagnosed as a cutaneous immune-related adverse event ...
Camille M. Powers   +6 more
doaj   +1 more source

Structure, function and inhibition of poly(ADP-ribose)polymerase, member 14 (PARP14) [PDF]

open access: yes, 2018
Levonis, Stephan M   +3 more
core   +1 more source

Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review [PDF]

open access: hybrid, 2018
Paul Emery   +6 more
openalex   +1 more source

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy

open access: yesJAAD Case Reports, 2021
Danielle M. Peterson, MD   +1 more
doaj   +1 more source

Supplementary Tables 1-4 from Debio 0617B Inhibits Growth of STAT3-Driven Solid Tumors through Combined Inhibition of JAK, SRC, and Class III/V Receptor Tyrosine Kinases

open access: gold, 2023
Maximilien Murone   +20 more
openalex   +1 more source

JAK inhibitors and alopecia areata [PDF]

open access: yesThe Lancet, 2019
Amos, Gilhar, Aviad, Keren, Ralf, Paus
openaire   +2 more sources

Hypoglycaemia following JAK inhibitor treatment in patients with diabetes

open access: green, 2021
Jette A. van Lint   +10 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy